IMCOR PHARMACEUTICAL CO 5
5 · IMCOR PHARMACEUTICAL CO · Filed Feb 17, 2005
Insider Transaction Report
Form 5
OXFORD BIOSCIENCE PARTNERS IV LP
10% Owner
Transactions
- Award
Common Stock
2004-09-28$0.13/sh+335,099$43,563→ 43,491,797 total - Award
Common Stock
2004-10-28$0.06/sh+726,049$43,563→ 44,217,846 total - Award
Common Stock
2004-11-28$0.20/sh+217,815$43,563→ 44,435,661 total - Award
Common Stock
2004-12-28$0.55/sh+79,205$43,563→ 44,514,866 total
Footnotes (2)
- [F1]Pursuant to Section 2(c) of the Issuer's Registration Rights Agreements dated April 19, 2004 and June 30, 2004, the Issuer issued such shares as liquidated damages in respect of the delayed effectiveness of the Issuer's resale registration statement for the applicable period.
- [F2]Prior to receiving the shares in respect of the late effectiveness of the resale registration statement, the reporting person adjusted the holdings it reported on July 2, 2004 of 43,333,382 to reflect a decrease of 176,684 shares of common stock to correct a miscalcuation of shares issued in connection with the prior conversion of interest payments, resulting in a revised opening balance for this Form 5 of 43,156,698.